Investor Relations

SEC Filings

Document Details

Form
Filing Date
Nov 10, 2021
Document Date
Sep 30, 2021
Form Description
Quarterly report which provides a continuing view of a company's financial position
Filing Group
Quarterly Filings
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.